Fennec Pharmaceuticals Financial Overview
Fennec Pharmaceuticals's market cap is currently $224.63M. The company's EPS TTM is $-0.019996424; its P/E ratio is -18.84; Fennec Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
